-0.69 | -3.39%
| Price and Volume | |
|---|---|
| Recent Price | 20.33 |
| 52 Week High | 24.65 |
| 52 Week Low | 12.90 |
| Avg. Daily Vol. (Mil) | 3.20 |
| Beta (3 year) | 1.50 |
| Share Related Items | |
| Mkt Cap (Mil) | 5,091.07 |
| Shares Out (Mil) | 250.42 |
| Float (Mil) | 167.18 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.70 |
| Current Ratio | 1.00 |
| LT Debt/ Equity | 19.82 |
| Total Debt / Equity | 20.64 |
| Valuation Ratios | |
| Price Earnings | 16.80 |
| Price/Sales | 1.92 |
| Price/Book | 30.12 |
| Price/Cash Flow | 5.30 |
| Per Share Data | |
| Earnings | 1.21 |
| Sales | 10.61 |
| Book Value | 0.67 |
| Cash Flow | 3.84 |
| Business Summary | |
|---|---|
| A pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. | |
| General Information | |
| Ardee Business Park
Unit 19 Ardee, Co. Louth, |
|
| www.warnerchilcott.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 2200 | |
| CEO: Roger M. Boissonneault | |
| Short Interest | |
| Current Month (Mil) | 6.16 |
| Previous Month (Mil) | 2.78 |
| Short Interest Ratio (Days) | 1.30 |
| Management Effectiveness | |
| Return on Equity | 182.00 |
| Return on Assets | 6.60 |
| Return on Investments | 8.80 |
| Profitability | |
| Gross Margin | 91.30 |
| EBIT Margin | 26.00 |
| Profit Margin | 11.60 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet